In 2022, the global empty capsules market was worth around USD 2,818 million, and it is projected to advance at a 7.10% CAGR from 2022 to 2030, hitting USD 4,879 million by 2030, according to P&S Intelligence.
This growth can be credited to the rising acceptance of encapsulated medications among the elderly populace and the subsequent high demand for empty shells in the pharmaceutical, nutraceutical, and cosmeceutical industries.
Furthermore, the increasing number of research and development initiatives by companies and governments for novel medications and molecules, the growing count of medical trials, and forward-moving drug delivery technologies are boosting the industry.
Nutraceutical items, numerous of which are formed from whole grains, are typically rich in fiber, antioxidants, omega-3 fatty acids, vitamins and minerals, and heart-healthy ingredients. In recent years, the need for nutraceuticals has swiftly augmented because of the increasing occurrence of non-infectious illnesses, including diabetes, cancer, lung disorders, and heart ailments.
Moreover, the rising consumer knowledge regarding the health advantages of such items in disease avoidance and health augmentation is boosting their consumption. Henceforth, as the majority of nutraceuticals are retailed in the form of capsules, the demand for empty shells is increasing.
The key features boosting the empty capsules market are the increasing focus on pre-emptive care and the growing commercialization of gelatine-capsule-based medicine delivery arrangements. Thus, on the basis of type, in 2022, gelatin capsules held a higher revenue share, of above 82%, and this category is further projected to maintain its supremacy in the future as well.
In 2022, the immediate-release category generated a higher revenue share, and also the category is projected to be in the leading spot throughout the projection period. This can be credited to the fast-release form is extensively used for making painkillers, antacids, antibiotics, and several other types of medications, credited to its benefit of the fast onset of action.
This form offers an immediate breakdown of the capsules in the stomach, after incorporation. Decreasing the breakdown time advances the rate at which medications dissolve. Moreover, it is extensively utilized for making dietary supplements.
In 2022, with approximately 37%, market share North America dominated the empty capsules market, and is also projected to be dominant in the future as well. This can be credited to the presence of a substantial count of businesses with high-volume capsule manufacturing abilities and the utilization of this dosage form by a count of pharmaceutical titans.
Hence, the rising acceptance of encapsulated medications among the elderly populace and the subsequent high demand for empty shells in the pharmaceutical, nutraceutical, and cosmeceutical industries. Furthermore, the increasing number of research and development initiatives by companies and governments are the major factors propelling the empty capsules market.